Vanberra Signal

Man’s Best Friends Therapeutics

Curated by Signal

Developer of vaccines for animal health

Overview

MBF Therapeutics is developing turbo-charged vaccines for animal health. It has developed gene-based checkpoint inhibitor and immune-modulators for cancer and infectious diseases for the companion animal market using both viral and non-viral proprietary delivery systems.

Key facts

Founded
2008

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of fertility tracking platform

    Health TechnologyNew York City, United States
  • Application platform to improve the health and well-being of people

    Health TechnologyGreenwood, United States

About Man’s Best Friends Therapeutics

What does Man’s Best Friends Therapeutics do?

MBF Therapeutics is developing turbo-charged vaccines for animal health.

Where is Man’s Best Friends Therapeutics headquartered?

Man’s Best Friends Therapeutics is headquartered in Ambler, United States.

When was Man’s Best Friends Therapeutics founded?

Man’s Best Friends Therapeutics was founded in 2008.

Which sector is Man’s Best Friends Therapeutics in?

Man’s Best Friends Therapeutics operates in Health Technology.

Who are Man’s Best Friends Therapeutics's competitors?

Companies similar to Man’s Best Friends Therapeutics include Oova, Preventia Group, and Flex Motion Technologies.